Faculty profile

Vidal Essebag

ResearcherCardiologyUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.

Vidal Essebag

Researcher

Cardiology

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
1 publication in the last five years, latest in 2023.
Principal investigator on 3 research grants (3 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

2,842

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clinical Health Systems/Services Cardiac Arrhythmias- Atrial Fibrillation Catheter Ablation

Latest papers

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy
New England Journal of Medicine · 2023
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
New England Journal of Medicine · 2021
Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
Circulation. Arrhythmia and electrophysiology · 2018

All 11 publications

Latest funding

Ablation Strategy for Paroxysmal Atrial Fibrillation - Trigger and Substrate Guided Wide Area RadiofrEquency Ablation Compared to Cryoablation Pulmonary Vein Isolation- A Patient Specific Precise Approach To Paroxysmal Atrial Fibrillation Ablation: AWARE-2 RCT
CIHR · 2022 · Principal investigator
$1,782,450
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (COAST-AF) Randomized Controlled Trial
CIHR · 2020 · Co-investigator
$952,426
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial
CIHR · 2020 · Co-investigator
$956,250

All 10 grants and awards

11 publications.

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy

Yung D, Jolly U, Wardell S, Kochhäuser S, Deyell MW, Macle L, Wells GA, Bennett M, Essebag V, Champagne J

New England Journal of Medicine2023385 citations

DOI: 10.1056/nejmoa2212540

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation

Yung D, Jolly U, Wardell S, Andrade JG, Wells GA, Deyell MW, Bennett M, Essebag V, Champagne J, Roux J-F

New England Journal of Medicine2021795 citationsOpen Access

DOI: 10.1056/nejmoa2029980 PMID: W3101635021

Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).

Parkash R, Nault I, Rivard L, Gula L, Essebag V, Nery P, Tung S, Raymond JM, Sterns L, Doucette S, Wells G, Tang ASL, Stevenson WG, Sapp JL

Circulation. Arrhythmia and electrophysiology2018

DOI: 10.1161/circep.117.005663 PMID: 29305400

Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing

Bennett MT, Leader N, Sapp J, Parkash R, Gardner M, Healey JS, Thibault B, Sterns L, Essebag V, Birnie D

Circulation: Arrhythmia and Electrophysiology20182 citations

DOI: 10.1161/circep.117.005921

Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients

Sapp JL, Parkash R, Wells GA, Yetisir E, Gardner MJ, Healey JS, Thibault B, Sterns LD, Birnie D, Nery PB

Circulation: Arrhythmia and Electrophysiology201747 citations

DOI: 10.1161/circep.116.004875

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs

Blier L, Tung SK, Veenhuyzen GD, Sapp JL, Wells GA, Parkash R, Stevenson WG, Sarrazin J-F, Thibault B, Rivard L

New England Journal of Medicine2016859 citations

DOI: 10.1056/nejmoa1513614

Incidence, Predictors, and Procedural Results of Upgrade to Resynchronization Therapy

Essebag V, Joza J, Birnie DH, Sapp JL, Sterns LD, Philippon F, Yee R, Crystal E, Kus T, Rinne C

Circulation: Arrhythmia and Electrophysiology201532 citationsFirst author

DOI: 10.1161/circep.114.001997

Management of Anticoagulation Around Pacemaker and Defibrillator Surgery

Birnie DH, Healey JS, Essebag V

Circulation201424 citationsSenior author

DOI: 10.1161/circulationaha.113.006027

Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TLL, Essebag V

New England Journal of Medicine2013558 citationsSenior author

DOI: 10.1056/nejmoa1302946

Clinical Predictors of Fidelis Lead Failure

Birnie DH, Parkash R, Exner DV, Essebag V, Healey JS, Verma A, Coutu B, Kus T, Mangat I, Ayala-Paredes F

Circulation2012107 citations

DOI: 10.1161/circulationaha.111.053744

Something wrong or missing on this profile? Suggest a correction

Vidal Essebag

Research

Latest papers

Latest funding

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation

Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).

Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing

Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs

Incidence, Predictors, and Procedural Results of Upgrade to Resynchronization Therapy

Management of Anticoagulation Around Pacemaker and Defibrillator Surgery

Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

Clinical Predictors of Fidelis Lead Failure

Frequent collaborators

Jeff Healey

Vidal Essebag

Ratika Parkash

Atul Verma

Ratika Parkash

Ratika Parkash

John Sapp

John Sapp

Pablo Nery

George Wells

David Birnie

Pablo Nery

Laurent Macle

Léna Rivard

Atul Verma

Sandra Lauck

George Wells

David Birnie

Guy Amit

Anthony Tang

Julia Cadrin-Tourigny

George Wells

Jacqueline Joza

Paul Dorian

Anthony Tang

Anthony Tang

George Wells

Damian Redfearn